{"id":101237,"date":"2025-10-24T10:18:06","date_gmt":"2025-10-24T10:18:06","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/101237\/"},"modified":"2025-10-24T10:18:06","modified_gmt":"2025-10-24T10:18:06","slug":"covid-19-mortality-among-people-living-with-hiv-aids-in-brazil-a-multilevel-analysis-aids-research-and-therapy","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/101237\/","title":{"rendered":"COVID-19 mortality among people living with HIV\/AIDS in Brazil: a multilevel analysis | AIDS Research and Therapy"},"content":{"rendered":"<p>In this study, we demonstrated the association between HIV infection and COVID-19 death in the Brazilian population from 2020 to 2022, considering different periods of dominance of variants of concern and vaccine rollout. Additionally, our study identified age group as an effect modifier of HIV on COVID-19 mortality. Age is the primary determinant of COVID-19 mortality in the general population, with several studies highlighting a substantially higher risk of death in individuals over 65\u00a0years of age [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Henkens MTHM, Raafs AG, Verdonschot JAJ, Linschoten M, Van Smeden M, Wang P, et al. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatr. 2022;22:184.\" href=\"#ref-CR35\" id=\"ref-link-section-d3848094e2458\">35<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Garcia-Calavaro C, Paternina-Caicedo A, Smith AD, Harrison LH, De La Hoz-Restrepo F, Acosta E, et al. COVID-19 mortality needs age adjusting for international comparisons. J Med Virol. 2021;93:4127\u20139.\" href=\"#ref-CR36\" id=\"ref-link-section-d3848094e2458_1\">36<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Levin AT, Hanage WP, Owusu N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, &amp; public policy implications [Internet]. National Bureau of Economic Research; 2020. &#10;                  https:\/\/www.nber.org\/papers\/w27597&#10;                  &#10;                . Accessed 13 Apr 2024\" href=\"#ref-CR37\" id=\"ref-link-section-d3848094e2458_2\">37<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 38\" title=\"Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20:669\u201377.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR38\" id=\"ref-link-section-d3848094e2461\" rel=\"nofollow noopener\" target=\"_blank\">38<\/a>]. However, when it comes to PLWHA, the relationship between the risk (or odds) of death and age is reversed [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 39\" title=\"Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, et al. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO) clinical characterization protocol (UK): a prospective observational study. Clin Infect Dis. 2021;73:e2095\u2013106.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR39\" id=\"ref-link-section-d3848094e2464\" rel=\"nofollow noopener\" target=\"_blank\">39<\/a>]. Our findings indicate that in the general population, the effect of age on COVID-19 mortality was evident, with the odds of death increasing with age across most periods (Supplementary tables 4\u20135). By contrast, older adults living with HIV (80+ years) had higher odds of COVID-19 death during all periods of variant dominance. Similarly, younger PLWHA, aged 18\u201339, showed higher odd of COVID-19 death during the pre-VOC, Delta, and Omicron periods.<\/p>\n<p>Evidence in the literature regarding the association between HIV and COVID-19 death is heterogeneous and divergent, with few studies considering the dominant variant or vaccination coverage. While initial studies conducted with small groups during the pre-VOC variant dominance period suggested no increased risk of severity or mortality from COVID-19 among PLWHA [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 11\" title=\"Dzinamarira T, Murewanhema G, Chitungo I, Ngara B, Nkambule SJ, Madziva R, et al. Risk of mortality in HIV-infected COVID-19 patients: a systematic review and meta-analysis. J Infect Public Health. 2022;15:654\u201361.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR11\" id=\"ref-link-section-d3848094e2470\" rel=\"nofollow noopener\" target=\"_blank\">11<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Danwang C, Noubiap JJ, Robert A, Yombi JC. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis. AIDS Res Ther. 2022;19:3.\" href=\"#ref-CR40\" id=\"ref-link-section-d3848094e2473\">40<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 1999;2020(85):6\u201310.\" href=\"#ref-CR41\" id=\"ref-link-section-d3848094e2473_1\">41<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 42\" title=\"Cabello A, Zamarro B, Nistal S, Victor V, Hern\u00e1ndez J, Prieto-P\u00e9rez L, et al. COVID-19 in people living with HIV: a multicenter case-series study. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2021;102:310\u20135.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR42\" id=\"ref-link-section-d3848094e2476\" rel=\"nofollow noopener\" target=\"_blank\">42<\/a>], an analysis of a cohort comprising data from 17,282,905 adults in the United Kingdom found that, during the pre-VOC period, PLWHA had an almost threefold higher risk of COVID-19 mortality (HR\u2009=\u20092.90; 95% CI: 1.96\u20134.30) compared to the HIV-negative population [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 43\" title=\"Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, et al. HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021;8:e24-32.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR43\" id=\"ref-link-section-d3848094e2479\" rel=\"nofollow noopener\" target=\"_blank\">43<\/a>]. Similar results were identified in a cohort of 204,583 COVID-19 cases recorded by the NYC Department of Health and Mental Hygiene during the pre-VOC period, where COVID-19 mortality was 1.62 times higher among PLWHA [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 44\" title=\"Braunstein SL, Lazar R, Wahnich A, Daskalakis DC, Blackstock OJ. Coronavirus disease 2019 (COVID-19) infection among people with human immunodeficiency virus in New York City: a population-level analysis of linked surveillance data. Clin Infect Dis. 2021;72:e1021\u20139.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR44\" id=\"ref-link-section-d3848094e2482\" rel=\"nofollow noopener\" target=\"_blank\">44<\/a>].<\/p>\n<p>Our results demonstrated that only PLWHA aged 18 to 39 and those in the oldest age group had higher odds of death from COVID-19 during the pre-VOC period. In contrast, PLWHA aged 40\u201379 showed lower odds of death from COVID-19 compared to individuals without HIV in the same age group during the same period. However, it is important to note that the interaction between age and HIV was not investigated in the referred studies.<\/p>\n<p>It is important to highlight that there was a high variation in case fatality rates among the different VOCs worldwide, with the Beta variant having the highest case fatality rate at 4.19%, followed by the Gamma variant at 3.60%. The Alpha and Delta variants had case fatality rates of 2.62 and 2.01%, respectively, while the Omicron variant had the lowest case fatality rate at 0.70% among all variants [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 45\" title=\"Xia Q, Yang Y, Wang F, Huang Z, Qiu W, Mao A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2024;141:106950.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR45\" id=\"ref-link-section-d3848094e2491\" rel=\"nofollow noopener\" target=\"_blank\">45<\/a>].<\/p>\n<p>During the dominance periods of VOCs, conflicting results have been reported regarding COVID-19 mortality among PLWHA. Some meta-analyses have found a higher risk of mortality among PLWHA compared to the general population, particularly during waves preceding Omicron [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11:6283.\" href=\"#ref-CR46\" id=\"ref-link-section-d3848094e2498\">46<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Hariyanto TI, Rosalind J, Christian K, Kurniawan A. Human immunodeficiency virus and mortality from coronavirus disease 2019: a systematic review and meta-analysis. South Afr J HIV Med. 2021;22:1220.\" href=\"#ref-CR47\" id=\"ref-link-section-d3848094e2498_1\">47<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Mellor MM, Bast AC, Jones NR, Roberts NW, Ord\u00f3\u00f1ez-Mena JM, Reith AJM, et al. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS Lond Engl. 2021;35:F1-10.\" href=\"#ref-CR48\" id=\"ref-link-section-d3848094e2498_2\">48<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 49\" title=\"Wang Y, Xie Y, Hu S, Ai W, Tao Y, Tang H, et al. Systematic review and meta-analyses of the interaction between hiv infection and COVID-19: two years\u2019 evidence summary. Front Immunol. 2022;13:864838.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR49\" id=\"ref-link-section-d3848094e2501\" rel=\"nofollow noopener\" target=\"_blank\">49<\/a>], while others found no significant differences [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 11\" title=\"Dzinamarira T, Murewanhema G, Chitungo I, Ngara B, Nkambule SJ, Madziva R, et al. Risk of mortality in HIV-infected COVID-19 patients: a systematic review and meta-analysis. J Infect Public Health. 2022;15:654\u201361.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR11\" id=\"ref-link-section-d3848094e2504\" rel=\"nofollow noopener\" target=\"_blank\">11<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 40\" title=\"Danwang C, Noubiap JJ, Robert A, Yombi JC. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis. AIDS Res Ther. 2022;19:3.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR40\" id=\"ref-link-section-d3848094e2507\" rel=\"nofollow noopener\" target=\"_blank\">40<\/a>].<\/p>\n<p>These divergences may stem from methodological limitations, such as the absence of sensitivity analyses considering the dominant VOC, as well as heterogeneity in the populations and periods analyzed. Notably, one of the largest international multicenter studies, conducted by the WHO Global Clinical Platform, found that PLWHA had consistently higher mortality risks across the pre-Delta, Delta, and Omicron waves, with the highest risk observed during the Omicron wave [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 10\" title=\"Bertagnolio S, Inzaule S, Silva R, Thwin SS, Jassat W, Ford N et al. High in-hospital mortality in SARS-CoV-2 infected patients living with HIV during pre-Delta, Delta and Omicron variant waves: findings from the WHO Global Clinical Platform for COVID-19. IAS 2023 Abstr Book [Internet]. 2023. p. 780. &#010;                  https:\/\/www.iasociety.org\/sites\/default\/files\/IAS2023\/abstract-book\/IAS_2023__Abstracts.pdf&#010;                  &#010;                . Accessed 19 Apr 2023\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR10\" id=\"ref-link-section-d3848094e2513\" rel=\"nofollow noopener\" target=\"_blank\">10<\/a>].<\/p>\n<p>In our study, the dominance of the Gamma variant, with a worldwide case fatality rate of 3.60% [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 45\" title=\"Xia Q, Yang Y, Wang F, Huang Z, Qiu W, Mao A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2024;141:106950.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR45\" id=\"ref-link-section-d3848094e2519\" rel=\"nofollow noopener\" target=\"_blank\">45<\/a>], was associated with lower odds of death among PLWHA across most age groups, except for those over 80\u00a0years. By contrast, the highest odds of death among PLWHA were observed during the Omicron dominance period, despite this variant having the lowest case fatality rates in the general population [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 45\" title=\"Xia Q, Yang Y, Wang F, Huang Z, Qiu W, Mao A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2024;141:106950.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR45\" id=\"ref-link-section-d3848094e2522\" rel=\"nofollow noopener\" target=\"_blank\">45<\/a>]. These findings suggest that the differential impact of VOCs on PLWHA may reflect the interaction between altered immune responses and variant-specific characteristics, such as immune escape and virulence. The widespread use of antiretroviral therapies (ARTs), particularly regimens containing tenofovir and lamivudine, may also have provided protective effects for their potential inhibitory action on the SARS-CoV-2. In Brazil, tenofovir and lamivudine are part of the preferred first-line ART regimens [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 50\" title=\"UNAIDS. HIV estimates with uncertainty bounds 1990-Present [Internet]. 2023. &#010;                  https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/HIV_estimates_with_uncertainty_bounds_1990-present&#010;                  &#010;                . Accessed 19 Apr 2024\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR50\" id=\"ref-link-section-d3848094e2525\" rel=\"nofollow noopener\" target=\"_blank\">50<\/a>].<\/p>\n<p>The variation in the odds of death among PLWHA during different periods of VOC dominance also underscores the influence of contextual factors such as vaccination coverage. Vaccination coverage, which is inversely related to case fatality rates [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 45\" title=\"Xia Q, Yang Y, Wang F, Huang Z, Qiu W, Mao A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2024;141:106950.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR45\" id=\"ref-link-section-d3848094e2531\" rel=\"nofollow noopener\" target=\"_blank\">45<\/a>], likely played a significant role in shaping COVID-19 mortality outcomes. Notably, the periods of VOC dominance coincided with vaccine rollout phases, suggesting that part of the observed effect may be attributable to vaccination levels rather than the variants themselves [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 45\" title=\"Xia Q, Yang Y, Wang F, Huang Z, Qiu W, Mao A. Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2024;141:106950.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR45\" id=\"ref-link-section-d3848094e2534\" rel=\"nofollow noopener\" target=\"_blank\">45<\/a>]. In our study, during the vaccination expansion period, the odds of death were lower among PLWHA for all age groups, except for the oldest adults. Notably, PLWHA were prioritized for COVID-19 vaccination alongside older adults, individuals with comorbidities, and other immunocompromised groups. During the consolidated vaccination period, which overlaps with the Omicron dominance, having HIV was associated with higher odds of death in all age groups, with the most notable increases observed in the 18\u201339 and 80+ age groups.<\/p>\n<p>Even though PLWHA may have lower seroconversion rates, particularly among those with lower baseline CD4+ counts or higher viral loads [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 51\" title=\"Chun HM, Milligan K, Agyemang E, Ford N, Rangaraj A, Desai S et al. A systematic review of COVID-19 vaccine antibody responses in people with HIV. Open Forum Infect Dis. 2022;9:ofac579.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR51\" id=\"ref-link-section-d3848094e2540\" rel=\"nofollow noopener\" target=\"_blank\">51<\/a>], evidence shows that after a booster dose, immune response rates become similar to those of HIV-negative individuals [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 52\" title=\"Cheng M-Q, Li R, Weng Z-Y, Song G. Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis. Front Med. 2023;10:1275843.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR52\" id=\"ref-link-section-d3848094e2543\" rel=\"nofollow noopener\" target=\"_blank\">52<\/a>]. However, this response varied depending on the dominant VOC, with lower immune responses observed against the Omicron variant [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 52\" title=\"Cheng M-Q, Li R, Weng Z-Y, Song G. Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis. Front Med. 2023;10:1275843.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR52\" id=\"ref-link-section-d3848094e2546\" rel=\"nofollow noopener\" target=\"_blank\">52<\/a>]. Additionally, fully vaccinated PLWHA have been shown to have a higher risk of COVID-19 diagnosis and death compared to HIV-negative individuals [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 53\" title=\"Coburn SB, Humes E, Lang R, Stewart C, Hogan BC, Gebo KA, et al. COVID-19 infections post-vaccination by HIV status in the United States. MedRxiv Prepr Serv Health Sci. 2021;2021.12.02.21267182.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR53\" id=\"ref-link-section-d3848094e2549\" rel=\"nofollow noopener\" target=\"_blank\">53<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 54\" title=\"Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, et al. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ. 2021;374:n2244.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR54\" id=\"ref-link-section-d3848094e2552\" rel=\"nofollow noopener\" target=\"_blank\">54<\/a>].<\/p>\n<p>These findings underscore the necessity of integrating the specific vulnerabilities of PLWHA into public health planning and policy formulation for pandemic response and other health emergencies. The identification of distinct mortality patterns among PLWHA across different pandemic periods suggests that universal strategies may be insufficient to ensure equitable protection for this population. Therefore, future emergency response guidelines should incorporate tailored approaches for PLWHA, including sustained prioritization for vaccination, enhanced monitoring of immune responses, uninterrupted access to antiretroviral therapy, and the integration of HIV care into broader pandemic response strategies. These measures are essential to mitigate the disproportionate impacts observed and to ensure a more equitable and effective public health response in future crises.<\/p>\n<p>The results of this study revealed a heterogeneous impact of HIV on COVID-19 mortality across Brazil\u2019s federative units, characterized by an inverse relationship between the average odds of COVID-19 death in the population and the effect of HIV on mortality. States with higher average odds of COVID-19 death tended to exhibit a reduced impact of HIV, suggesting that contextual factors unique to each location significantly influence these outcomes.<\/p>\n<p>Regional disparities in social conditions and healthcare access across Brazil\u2019s five geographic regions further explain these variations. The highest odds ratios for COVID-19 death among PLWHA were observed in the North and Northeast regions, where the disease burden remains significantly higher compared to the Southeast and South [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 55\" title=\"GBD 2016 Brazil Collaborators. Burden of disease in Brazil, 1990\u20132016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet Lond Engl. 2018;392:760\u201375.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR55\" id=\"ref-link-section-d3848094e2565\" rel=\"nofollow noopener\" target=\"_blank\">55<\/a>]. This disparity persisted and even intensified during the COVID-19 pandemic, particularly in the North [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 56\" title=\"Silva GAE, Jardim BC, Lotufo PA. Mortalidade por COVID-19 padronizada por idade nas capitais das diferentes regi\u00f5es do Brasil. Cad Sa\u00fade P\u00fablica. 2021;37:e00039221.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR56\" id=\"ref-link-section-d3848094e2568\" rel=\"nofollow noopener\" target=\"_blank\">56<\/a>]. Although studies on COVID-19 mortality among PLWHA in Brazil remain scarce, existing analyses are concentrated in the Southeast. A cohort study conducted in S\u00e3o Paulo during the early phase of the pandemic found no increased risk of COVID-19 mortality among PLWHA, suggesting that comorbidities, rather than HIV status itself, were the main determinants of severe outcomes [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 57\" title=\"Monteiro MA, Prates GS, De Lima Nascimento NA, Veiga APR, Magri MMC, Polis TJB, et al. SARS-CoV-2\/COVID-19: clinical course among subjects HIV-1-infectedin Sao Paulo. Curr HIV Res. 2022;20:457\u201362.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR57\" id=\"ref-link-section-d3848094e2571\" rel=\"nofollow noopener\" target=\"_blank\">57<\/a>]. However, while comorbidities have a well-established impact on COVID-19 mortality, it is important to note that their prevalence is consistently higher among PLWHA compared to the general population and may act as mediators in the relationship between HIV and COVID-19 outcomes rather than confounders, potentially underestimating the independent contribution of HIV to COVID-19 mortality risk.<\/p>\n<p>Research in the Southeast region identified a case-fatality rate of 34% among PLWHA with severe acute respiratory syndrome, with social vulnerabilities playing a significant role in mortality risk [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 58\" title=\"Rocha SQ, Avelino-Silva VI, Tancredi MV, Jamal LF, Ferreira PRA, Tayra A, et al. COVID-19 and HIV\/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling. AIDS Care. 2022;34:832\u20138.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR58\" id=\"ref-link-section-d3848094e2577\" rel=\"nofollow noopener\" target=\"_blank\">58<\/a>]. Other study highlighted the impact of the pandemic on HIV care, demonstrating that linkage and retention strategies helped mitigate disruptions in treatment access [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 59\" title=\"Matsuda EM, Oliveira IPD, Bao LB, Manzoni FM, Campos NC, Varej\u00e3o BB, et al. Impact of covid-19 on people living with HIV-1: care and prevention indicators at a local and nationwide level, Santo Andr\u00e9, Brazil. Rev Sa\u00fade P\u00fablica. 2022;56:37.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR59\" id=\"ref-link-section-d3848094e2580\" rel=\"nofollow noopener\" target=\"_blank\">59<\/a>]. The only nationwide assessment comparing hospitalized COVID-19 patients with and without HIV found a higher in-hospital mortality rate among PLWHA in 2020, though this difference was no longer observed in 2021 [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 60\" title=\"Sales TLS, Souza-Silva MVR, Delfino-Pereira P, Neves JVB, Sacioto MF, Assis VCMD, et al. COVID-19 outcomes in people living with HIV: peering through the waves. Clinics. 2023;78:100223.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR60\" id=\"ref-link-section-d3848094e2583\" rel=\"nofollow noopener\" target=\"_blank\">60<\/a>]. However, this analysis did not account for regional disparities, dominant SARS-CoV-2 variants, or vaccination coverage, all of which may have influenced the observed outcomes. To our knowledge, our research is the first to analyze COVID-19 mortality among PLWHA at the national level in Brazil, incorporating data from all federative units while also accounting for the influence of variant dominance and vaccination coverage over time.<\/p>\n<p>Several limitations must be acknowledged in this study. First, it was not possible to estimate the effects of other sociodemographic variables such as race\/ethnicity on the odds of COVID-19 death among PLWHA. This is particularly relevant given the well-documented racial and regional health disparities in Brazil, both before and during the pandemic period [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Calazans JA, Guimar\u00e3es R, Nepomuceno MR. Diferenciais regionais da mortalidade no Brasil: contribui\u00e7\u00e3o dos grupos et\u00e1rios e de causas de \u00f3bito sobre a varia\u00e7\u00e3o da esperan\u00e7a de vida e da dispers\u00e3o da idade \u00e0 morte entre 2008 e 2018. Rev Bras Estud Popul. 2023;40:1\u201323.\" href=\"#ref-CR61\" id=\"ref-link-section-d3848094e2589\">61<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Caro-Vega Y, Belaunzar\u00e1n-Zamudio PF, Crabtree-Ram\u00edrez B, Shepherd BE, Mejia F, Giganti MJ, et al. Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge. Epidemiol Infect. 2018;146:1308\u201311.\" href=\"#ref-CR62\" id=\"ref-link-section-d3848094e2589_1\">62<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Pedroso AO, Gomes D, Sousa SML, Ferreira GRON, Ramos AMPC, Polaro SHI, et al. Temporal and spatial analysis techniques as potential tools for combating the HIV epidemic among young Brazilian Amazonian people: an ecological study. Trop Med Infect Dis. 2022;7:137.\" href=\"#ref-CR63\" id=\"ref-link-section-d3848094e2589_2\">63<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Polidoro M, de Oliveira DC, Ferreira AR, Baniwa A. Epidemiological and spatial disparities of HIV\/AIDS in adults in Brazil: a comparative analysis between indigenous and non-indigenous populations. J Racial Ethn Health Disparities. 2025.\" href=\"#ref-CR64\" id=\"ref-link-section-d3848094e2589_3\">64<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 65\" title=\"Cajazeiro JMD, Cardoso AM, Nobre AA. Ethnic-racial composition of the population in COVID-19 mortality: a spatial ecological approach to Brazilian health inequalities. Cienc Saude Coletiva. 2024;29:e05552024.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR65\" id=\"ref-link-section-d3848094e2592\" rel=\"nofollow noopener\" target=\"_blank\">65<\/a>]. Although we adjusted for sex, age, and state of residence, which we believe was sufficient to control for major confounding, this approach does not fully capture the intersectional vulnerabilities that may exist. Nonetheless, the consistency of our results with the current understanding of HIV epidemic trends and regional disparities in Brazil supports the validity of our findings [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Calazans JA, Guimar\u00e3es R, Nepomuceno MR. Diferenciais regionais da mortalidade no Brasil: contribui\u00e7\u00e3o dos grupos et\u00e1rios e de causas de \u00f3bito sobre a varia\u00e7\u00e3o da esperan\u00e7a de vida e da dispers\u00e3o da idade \u00e0 morte entre 2008 e 2018. Rev Bras Estud Popul. 2023;40:1\u201323.\" href=\"#ref-CR61\" id=\"ref-link-section-d3848094e2595\">61<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Caro-Vega Y, Belaunzar\u00e1n-Zamudio PF, Crabtree-Ram\u00edrez B, Shepherd BE, Mejia F, Giganti MJ, et al. Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge. Epidemiol Infect. 2018;146:1308\u201311.\" href=\"#ref-CR62\" id=\"ref-link-section-d3848094e2595_1\">62<\/a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 63\" title=\"Pedroso AO, Gomes D, Sousa SML, Ferreira GRON, Ramos AMPC, Polaro SHI, et al. Temporal and spatial analysis techniques as potential tools for combating the HIV epidemic among young Brazilian Amazonian people: an ecological study. Trop Med Infect Dis. 2022;7:137.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR63\" id=\"ref-link-section-d3848094e2598\" rel=\"nofollow noopener\" target=\"_blank\">63<\/a>]. Additionally, this analysis incorporated a multilevel model that included contextual factors and accounted for local disparities, providing a more robust approach compared to standard methods. Moreover, the interaction between HIV status and age group was identified, further strengthening the model\u2019s capacity to reflect the complexity of these associations.<\/p>\n<p>Another limitation concerns the classification of vaccination periods. While this categorization was necessary to analyze the COVID-19 Mortality in PLWHA over time, it does not fully capture the heterogeneity in vaccine coverage at the individual or regional level. Vaccination rollout in Brazil was not uniform, with significant state-level variation in both access and adherence, which may have influenced the association between HIV status and COVID-19 mortality. Although the multilevel modeling approach accounted for regional disparities by including the state of residence as a random intercept, some degree of bias due to vaccination delays or differences in accessibility across states cannot be ruled out. Future studies incorporating more granular data, such as state-level vaccine coverage or individual vaccination status, would enhance model interpretability and analytical precision.<\/p>\n<p>In this research, we were concerned about the potential misclassification of individuals\u2019 HIV status in the death certificate due to underreporting, which could introduce a misclassification bias of the exposure. To mitigate this issue, we examined all mentioned causes of death, identifying HIV status based on the presence of ICD-10 codes for HIV\/AIDS in any field of the death certificate rather than relying solely on the underlying cause of death. This approach, previously employed in studies on causes of death in Brazil [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 66\" title=\"Paula AA, Schechter M, Tuboi SH, Faulhaber JC, Luz PM, Veloso VG, et al. Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data. Okulicz JF, organizador. PLoS ONE. 2014;9:e94636.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR66\" id=\"ref-link-section-d3848094e2607\" rel=\"nofollow noopener\" target=\"_blank\">66<\/a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 67\" title=\"Moreira R, Bastos LS, Carvalho LM, Freitas LP, Pacheco AG. Persistent high mortality rates for diabetes mellitus and hypertension after excluding deaths associated with COVID-19 in Brazil, 2020\u20132022. PLOS Glob Public Health. 2024;4:e0002576.\" href=\"http:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00759-z#ref-CR67\" id=\"ref-link-section-d3848094e2610\" rel=\"nofollow noopener\" target=\"_blank\">67<\/a>], aimed to capture all individuals with a documented HIV diagnosis. By incorporating multiple fields from mortality records, we sought to reduce underreporting and ensure a more comprehensive identification of PLWHA. However, the comparator group in our analysis, comprising the general population, may include PLWHA who were not diagnosed or not reported on death certificates. This inclusion may further attenuate the observed differences in mortality between groups. Any residual error from misclassification is likely non-differential, which would lead to an underestimation of the exposure effect on the outcome. Therefore, the odds ratios obtained in this study may be somewhat underestimated.<\/p>\n<p>Finally, the absence of clinical and laboratory data such as comorbidities, viral load, CD4+ count, and ART adherence limits our ability to assess how key clinical factors may act as confounders or mediators, thereby restricting the strength of causal inference in our findings.<\/p>\n<p>In summary, this study contributes to the understanding of the impact of COVID-19 pandemic among PLWHA in Brazil and provides a basis for future analyses. Further research should include individual-level data on viral load, CD4+ counts, and ART adherence to better understand the clinical factors associated with increased COVID-19 mortality risk among PLWHA. Stratified analyses by race\/ethnicity, socioeconomic status, and comorbidities will be essential to clarify the role of social disparities in shaping vulnerability to COVID-19 among PLWHA. Additionally, studies focusing on the Brazilian context, considering its regional specificities, are crucial due to the uniqueness of the country\u2019s geographical, sociodemographic characteristics, and healthcare system.<\/p>\n","protected":false},"excerpt":{"rendered":"In this study, we demonstrated the association between HIV infection and COVID-19 death in the Brazilian population from&hellip;\n","protected":false},"author":2,"featured_media":101238,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[160,62809,62810,103,14794,61,2757,60,8702,62808,9350,2748],"class_list":{"0":"post-101237","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-covid-19","9":"tag-effect-modifier","10":"tag-epidemiologic","11":"tag-health","12":"tag-hiv","13":"tag-ie","14":"tag-infectious-diseases","15":"tag-ireland","16":"tag-mortality","17":"tag-multilevel-analysis","18":"tag-sars-cov-2","19":"tag-virology"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/101237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=101237"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/101237\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/101238"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=101237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=101237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=101237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}